Oricell Therapeutics Stock

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Sign up today and learn more about Oricell Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Oricell Therapeutics Stock

OriCell Therapeutics develop drugs with good efficacy and affordable prices to satisfy the globally unmet clinical needs through innovations and strives to become the world-leading developer of novel drugs for tumor immunotherapy.

Funding History

June 2018$3.0M
December 2019$100M
January 2021$200M
August 2022$120M
February 2023$45.0M

Management

Board member

William Hu

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo